Submitted by Anonymous (not verified) on 24 October 2023 - 14:14
Human medicines European public assessment report (EPAR): Actelsar HCT, telmisartan,hydrochlorothiazide, Essential Hypertension, Date of authorisation: 13/03/2013, Revision: 17, Status: Authorised
Source: